PathMaker Neurosystems

PathMaker Neurosystems is a pre-commercialization-stage neuromodulation company aiming to commercialize the latest advancements in the development of non-invasive devices for treating patients with severe neurological disorders. Focused on rapidly bringing revolutionary products to market for the non-invasive treatment of spasticity and ALS (Amyotrophic Lateral Sclerosis), the company is advancing a completely new therapeutic paradigm based on multi-site neuromodulation. Backed by extensive preclinical animal studies, recent elucidation of molecular mechanisms, and published human clinical outcomes, its proprietary NeuroSynchronizer™ technology achieves modulation of neural activity through precisely sequenced, non-invasive stimulation at multiple body sites, enabling directionally controlled spinal-level regulation.